Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124615602 | 12461560 | 2 | F | 20160706 | 20160613 | 20160715 | EXP | GB-PFM-GB-2015-4997 | PIERRE FABRE MEDICAMENT | 82.00 | YR | F | Y | 0.00000 | 20160715 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124615602 | 12461560 | 1 | PS | VINORELBINE INN | VINORELBINE TARTRATE | 1 | Oral | UNK | U | U | 20388 | CAPSULE, SOFT | |||||||
| 124615602 | 12461560 | 2 | SS | VINORELBINE INN | VINORELBINE TARTRATE | 1 | Oral | UNK | U | U | 20388 | CAPSULE, SOFT | |||||||
| 124615602 | 12461560 | 3 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | 360 MG IN 267 ML | U | U | 0 | ||||||||
| 124615602 | 12461560 | 4 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | UNK | U | U | 0 | ||||||||
| 124615602 | 12461560 | 5 | SS | NEULASTA | PEGFILGRASTIM | 1 | Unknown | U | U | 0 | |||||||||
| 124615602 | 12461560 | 6 | SS | PERJETA | PERTUZUMAB | 1 | Intravenous (not otherwise specified) | 420 MG IN 264 ML | U | U | 0 | ||||||||
| 124615602 | 12461560 | 7 | SS | PERJETA | PERTUZUMAB | 1 | Intravenous (not otherwise specified) | UNK | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124615602 | 12461560 | 1 | Product used for unknown indication |
| 124615602 | 12461560 | 3 | Product used for unknown indication |
| 124615602 | 12461560 | 5 | Product used for unknown indication |
| 124615602 | 12461560 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124615602 | 12461560 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124615602 | 12461560 | Alopecia | |
| 124615602 | 12461560 | Axillary pain | |
| 124615602 | 12461560 | Cellulitis | |
| 124615602 | 12461560 | Dry mouth | |
| 124615602 | 12461560 | Dry skin | |
| 124615602 | 12461560 | Fatigue | |
| 124615602 | 12461560 | Malignant neoplasm progression | |
| 124615602 | 12461560 | Mass | |
| 124615602 | 12461560 | Mouth ulceration | |
| 124615602 | 12461560 | Muscle spasms | |
| 124615602 | 12461560 | Nail injury | |
| 124615602 | 12461560 | Onychoclasis | |
| 124615602 | 12461560 | Oral pain | |
| 124615602 | 12461560 | Pain in extremity | |
| 124615602 | 12461560 | Pain of skin | |
| 124615602 | 12461560 | Rash macular | |
| 124615602 | 12461560 | Soft tissue swelling | |
| 124615602 | 12461560 | Tongue ulceration | |
| 124615602 | 12461560 | Toxicity to various agents | |
| 124615602 | 12461560 | Tumour pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124615602 | 12461560 | 2 | 20151202 | 0 | ||
| 124615602 | 12461560 | 4 | 20151202 | 0 | ||
| 124615602 | 12461560 | 7 | 20151202 | 0 |